Evidence map›Paper›PMID 40389059›Full record

ReviewMetabolism: clinical and experimental2025

Overview of methods that determine mitochondrial function in human disease.

Eashan Sharma, Leila Fotooh Abadi, John Arnaud Kombe Kombe, Monisha Kandala, Jordan Parker, Nolan Winicki, Theodoros Kelesidis

Abstract readReview
In one paragraph

Review in Metabolism: clinical and experimental, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. The Protective Effect of N, Ce-doped Carbon Dots Against HApplied biochemistry and biotechnology · 2026
    Article
  8. Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eashan SharmaDepartment of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at the University of California, Los Angeles, California (UCLA), Los Angeles, CA, USA.
Leila Fotooh AbadiDepartment of Medicine, Division of Infectious Diseases, University of Texas Southwestern, Dallas, TX, USA.
John Arnaud Kombe KombeDepartment of Medicine, Division of Infectious Diseases, University of Texas Southwestern, Dallas, TX, USA.
Monisha KandalaDepartment of Medicine, Division of Infectious Diseases, University of Texas Southwestern, Dallas, TX, USA.
Jordan ParkerDepartment of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at the University of California, Los Angeles, California (UCLA), Los Angeles, CA, USA; Lexington Medical Center, West Columbia, SC, USA.
Nolan WinickiThe Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Theodoros KelesidisDepartment of Medicine, Division of Infectious Diseases, David Geffen School of Medicine at the University of California, Los Angeles, California (UCLA), Los Angeles, CA, USA; Department of Medicine, Division of Infectious Diseases, University of Texas Southwestern, Dallas, TX, USA. Electronic address: Theodoros.Kelesidis@UTSouthwestern.edu.

Funding

Targeting early instigators of vascular inflammation to prevent and/or delay vascular aging in chronic treated HIVR01AG059502 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI KELESIDIS, THEODOROS · 2018 to 2022
$2.0M
Mitoquinone/mitoquinol mesylate as oral and safe Postexposure Prophylaxis for Covid-19R21AI178632 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI KELESIDIS, THEODOROS · 2023 to 2025
$451k
In vivo modelling of therapeutic strategies for prevention of HIV-related fibrosis and fatty liver disease in chronic treated HIV-1 infectionR21AI136708 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KELESIDIS, THEODOROS · 2018 to 2019
$429k
Elucidating the impact of molecular signatures of immune senescence on aging in chronic treated HIVR03AG059462 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KELESIDIS, THEODOROS · 2018 to 2019
$156k
NIAID NIH HHS R21 AI136708NIAID NIH HHS R21 AI178632NIA NIH HHS R01 AG059502NIA NIH HHS R03 AG059462
6 · The paper itself

Abstract

Cellular metabolism has a key role in the pathogenesis of human disease. Mitochondria are the organelles that generate most of the energy needed for a cell to function and drive cellular metabolism. Understanding the link between metabolic and mitochondrial function can be challenging due to the variation in methods used to measure mitochondrial function and heterogeneity in mitochondria, cells, tissues, and end organs. Mitochondrial dysfunction can be determined at both the cellular and tissue levels using several methods, such as assessment of cellular bioenergetics, levels of mitochondrial DNA (mtDNA), mitochondrial membrane potential (MMP), mitochondrial reactive oxygen species (mito-ROS), and levels of mitochondrial enzymes. Recent advances involving novel radiotracers in combination with PET imaging have allowed for the determination of mitochondrial function in vivo with high specificity. Understanding the barriers in existing methodologies used to study mitochondrial function may help further establish the assessment of mitochondrial function as a biologically and clinically relevant biomarker for human disease severity and prognosis. Herein, we critically review the existing literature regarding the strengths and limitations of methods that determine mitochondrial function, and we subsequently discuss how emerging research methods have begun to overcome some of these hurdles. We conclude that a combination of techniques, including respirometry and mitochondrial membrane potential assessment, is necessary to understand the complexity and biological and clinical relevance of mitochondrial function in human disease.

Indexed as

MitochondriaMitochondrial DiseasesAnimalsDNA, MitochondrialEnergy MetabolismHumansMembrane Potential, MitochondrialPositron-Emission TomographyReactive Oxygen SpeciesDNA, MitochondrialReactive Oxygen SpeciesBiomarkersHuman diseaseMetabolismMitochondriaMitrochondrial function

Identifiers

PMID40389059
PMCPMC12250752

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.